Consonance Capital Management as of Sept. 30, 2017
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 20 positions in its portfolio as reported in the September 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Spectrum Pharmaceuticals | 13.6 | $123M | 8.7M | 14.07 | |
| Retrophin | 9.7 | $87M | 3.5M | 24.89 | |
| Amarin Corporation (AMRN) | 9.5 | $86M | 25M | 3.50 | |
| Ptc Therapeutics I (PTCT) | 8.7 | $79M | 3.9M | 20.01 | |
| Corcept Therapeutics Incorporated (CORT) | 8.3 | $75M | 3.9M | 19.30 | |
| Myriad Genetics (MYGN) | 7.9 | $71M | 2.0M | 36.18 | |
| La Jolla Pharmaceuticl Com Par | 7.7 | $70M | 2.0M | 34.78 | |
| Gw Pharmaceuticals Plc ads | 6.8 | $61M | 602k | 101.49 | |
| Advanced Accelerat spon ads each rep 2 ord | 6.7 | $60M | 891k | 67.62 | |
| Pacira Pharmaceuticals (PCRX) | 5.7 | $52M | 1.4M | 37.55 | |
| Keryx Biopharmaceuticals | 4.1 | $37M | 5.2M | 7.10 | |
| Pacific Biosciences of California (PACB) | 4.0 | $36M | 6.9M | 5.25 | |
| Vericel (VCEL) | 2.0 | $18M | 3.0M | 6.00 | |
| Corindus Vascular Robotics I | 2.0 | $18M | 12M | 1.52 | |
| Globus Med Inc cl a (GMED) | 1.8 | $17M | 555k | 29.72 | |
| Biosante Pharmaceuticals (ANIP) | 0.8 | $7.5M | 143k | 52.49 | |
| Adma Biologics (ADMA) | 0.4 | $3.9M | 1.3M | 3.08 | |
| D Stemline Therapeutics | 0.1 | $1.1M | 101k | 11.10 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.1 | $931k | 369k | 2.52 | |
| Seaspine Holdings | 0.1 | $489k | 44k | 11.21 |
